Concepedia

Holly Galavotti

HG

Statistics

Publications

6

Citations

968

H-Index

6

Active since

1999

Affiliations

University of Virginia(Current)

Carter Center

Holly Galavotti is an author at University of Virginia specializing in immunology, cancer immunotherapy, and antitumor t cell responses.

Publications per year

1999–2005

6

Publications

6

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov et al. · Journal of Clinical Oncology · 2003 · 321 citations

, , +17

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese et al. · PubMed · 2001 · 229 citations

, , +17

Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines

Laurence H. Brinckerhoff, Lee W. Thompson, Galina V. Yamshchikov et al. · International Journal of Cancer · 1999 · 168 citations

, , +17

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients

Galina V. Yamshchikov, Donna L. Barnd, Shannon Eastham et al. · International Journal of Cancer · 2001 · 115 citations

, , +17

Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma

Galina V. Yamshchikov, David W. Mullins, Chien‐Chung Chang et al. · The Journal of Immunology · 2005 · 93 citations · Full text

, , +17

1–5 of 6